MOS
ALXN

MGO One Seven’s Alexion Pharmaceuticals ALXN Stock Holding History

MGO One Seven’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,055
Closed -$1.11M – 652
2021
Q2 		$1.11M Sell
6,055
-579
-9% -$99.4K 0.16% 167
2021
Q1 		$1.01M Sell
6,634
-1,898
-22% -$294K 0.17% 147
2020
Q4 		$1.33M Sell
8,532
-74
-0.9% -$9.51K 0.27% 90
2020
Q3 		$985K Sell
8,606
-316
-4% -$34.1K 0.23% 105
2020
Q2 		$1M Buy
8,922
+122
+1% +$13K 0.26% 103
2020
Q1 		$790K Buy
+8,800
New +$864K 0.27% 96
2019
Q3 		– Sell
-1,586
Closed -$207K – 469
2019
Q2 		$207K Buy
1,586
+86
+6% +$11.1K 0.07% 365
2019
Q1 		$202K Buy
1,500
+687
+85% +$85.4K 0.07% 379
2018
Q4 		$79K Buy
+813
New +$96.1K 0.03% 530
2018
Q1 		$61K Buy
544
+7
+1% +$837 0.03% 559
2017
Q4 		$64K Buy
+537
New +$65.4K 0.03% 545

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

MGO One Seven's ALXN Position: Q3 2021 in Review

MGO One Seven sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 6,055 shares — an estimated $1.11M sold.

MGO One Seven first reported a position in ALXN in Q4 2017 and held it in 11 quarters. The position peaked at $1.33M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • MGO One Seven reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • MGO One Seven sold 6,055 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.11M.
  • MGO One Seven first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 11 quarters.
  • MGO One Seven's Alexion Pharmaceuticals position peaked at $1.33M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on MGO One Seven's 13F filing for Q3 2021, filed 9 Nov 2021.